Close Menu

NEW YORK — British molecular assay startup Biofidelity said today that it has raised £750,000 ($906,555) in seed funding.

Investors include UK-based Longwell Ventures, as well as an undisclosed multinational diagnostics firm and private investors.

Biofidelity, founded earlier this year, is developing a technology for the detection of low-frequency genetic mutations for diagnostic applications in areas including cancer and prenatal testing.   

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.